173 related articles for article (PubMed ID: 36680944)
21. DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy.
Tubbs JL; Pegg AE; Tainer JA
DNA Repair (Amst); 2007 Aug; 6(8):1100-15. PubMed ID: 17485252
[TBL] [Abstract][Full Text] [Related]
22. Lung cancer risk and variation in MGMT activity and sequence.
Povey AC; Margison GP; Santibáñez-Koref MF
DNA Repair (Amst); 2007 Aug; 6(8):1134-44. PubMed ID: 17569600
[TBL] [Abstract][Full Text] [Related]
23. MGMT hypermethylation: a prognostic foe, a predictive friend.
Jacinto FV; Esteller M
DNA Repair (Amst); 2007 Aug; 6(8):1155-60. PubMed ID: 17482895
[TBL] [Abstract][Full Text] [Related]
24. Critical appraisal of MGMT in digestive NET treated with alkylating agents.
de Mestier L; Couvelard A; Blazevic A; Hentic O; de Herder WW; Rebours V; Paradis V; Ruszniewski P; Hofland LJ; Cros J
Endocr Relat Cancer; 2020 Oct; 27(10):R391-R405. PubMed ID: 32698158
[TBL] [Abstract][Full Text] [Related]
25. BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression.
Tancredi A; Gusyatiner O; Bady P; Buri MC; Lomazzi R; Chiesi D; Messerer M; Hegi ME
Cell Death Dis; 2022 Dec; 13(12):1037. PubMed ID: 36513631
[TBL] [Abstract][Full Text] [Related]
26. Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.
Lavon I; Fuchs D; Zrihan D; Efroni G; Zelikovitch B; Fellig Y; Siegal T
Cancer Res; 2007 Sep; 67(18):8952-9. PubMed ID: 17875738
[TBL] [Abstract][Full Text] [Related]
27. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
[TBL] [Abstract][Full Text] [Related]
28. Harnessing an emissive guanine surrogate to design small-molecule fluorescent chemosensors of
Fillion A; Franco Pinto J; Granzhan A
Org Biomol Chem; 2022 Mar; 20(9):1888-1892. PubMed ID: 35174383
[TBL] [Abstract][Full Text] [Related]
29. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.
Naumann SC; Roos WP; Jöst E; Belohlavek C; Lennerz V; Schmidt CW; Christmann M; Kaina B
Br J Cancer; 2009 Jan; 100(2):322-33. PubMed ID: 19127257
[TBL] [Abstract][Full Text] [Related]
30. Alkyltransferase-like proteins.
Margison GP; Butt A; Pearson SJ; Wharton S; Watson AJ; Marriott A; Caetano CM; Hollins JJ; Rukazenkova N; Begum G; Santibáñez-Koref MF
DNA Repair (Amst); 2007 Aug; 6(8):1222-8. PubMed ID: 17500045
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR
Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865
[TBL] [Abstract][Full Text] [Related]
32. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma.
Wu S; Li X; Gao F; de Groot JF; Koul D; Yung WKA
Neuro Oncol; 2021 Jun; 23(6):920-931. PubMed ID: 33433610
[TBL] [Abstract][Full Text] [Related]
33. Repair of O6-carboxymethylguanine adducts by O6-methylguanine-DNA methyltransferase in human colon epithelial cells.
Kostka T; Empl MT; Seiwert N; Geisen SM; Hoffmann P; Adam J; Seeger B; Shay JW; Christmann M; Sturla SJ; Fahrer J; Steinberg P
Carcinogenesis; 2021 Aug; 42(8):1110-1118. PubMed ID: 34115837
[TBL] [Abstract][Full Text] [Related]
34. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.
Kristensen LS; Nielsen HM; Hager H; Hansen LL
Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446
[TBL] [Abstract][Full Text] [Related]
35. Modulation of
Thongararm P; Fedeles BI; Khumsubdee S; Armijo AL; Kim L; Thiantanawat A; Promvijit J; Navasumrit P; Ruchirawat M; Croy RG; Essigmann JM
Chem Res Toxicol; 2020 Feb; 33(2):625-633. PubMed ID: 31841318
[TBL] [Abstract][Full Text] [Related]
36. NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.
Tsuji S; Nakamura S; Shoda K; Yamada T; Shimazawa M; Nakayama N; Iwama T; Hara H
J Neurooncol; 2022 Nov; 160(2):375-388. PubMed ID: 36308592
[TBL] [Abstract][Full Text] [Related]
37. Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Baum C
DNA Repair (Amst); 2007 Aug; 6(8):1187-96. PubMed ID: 17482894
[TBL] [Abstract][Full Text] [Related]
38. O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry.
Christmann M; Verbeek B; Roos WP; Kaina B
Biochim Biophys Acta; 2011 Dec; 1816(2):179-90. PubMed ID: 21745538
[TBL] [Abstract][Full Text] [Related]
39. Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs.
Roos WP; Nikolova T; Quiros S; Naumann SC; Kiedron O; Zdzienicka MZ; Kaina B
DNA Repair (Amst); 2009 Jan; 8(1):72-86. PubMed ID: 18840549
[TBL] [Abstract][Full Text] [Related]
40. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.
Yousuf A; Bhat MY; Pandith AA; Afroze D; Khan NP; Alam K; Shah P; Shah MA; Mudassar S
Cell Oncol (Dordr); 2014 Aug; 37(4):245-52. PubMed ID: 25008999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
